{"raw_mentions": "Here are the extracted sentences that meet the criteria:\n\n* For example, maximum expression of a CAR comprising the trimethoprim-controlled DHFR RDD occurred at about 500 nM of trimethoprim, well within the compound's EC50 of 50 nM.\n* This is well within the mean steady-state plasma concentration of trimethoprim when taken 160 mg twice a day (1.72 \u03bcg/mL, about 6 \u03bcM)."}
{"final_json": [{"molecule_name": "trimethoprim", "protein_target_name": "DHFR", "binding_metric": "EC50", "value": "50", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "trimethoprim", "protein_target_name": null, "binding_metric": null, "value": "500", "unit": "nM", "is_logarithmic": false}, {"molecule_name": "trimethoprim", "protein_target_name": null, "binding_metric": null, "value": "6", "unit": "\u03bcM", "is_logarithmic": false}]}
{"raw_mentions": "In particular, as shown in Example 2, the IC50 (the time it takes for 50% of surface CAR to be degraded), was observed to be less than 2 hours in the absence of stabilizing drug/molecule (see Example 2, FIG. 13)."}
{"final_json": [{"molecule_name": null, "protein_target_name": "CAR", "binding_metric": "IC50", "value": "<2", "unit": "hours", "is_logarithmic": false}]}
